Brief: Reshape Lifesciences Receives FDA PMA Supplement Approval For Lap-Band® 2.0 Flex
Dec 12 (Reuters) - ReShape Lifesciences Inc RSLS.O :
* RESHAPE LIFESCIENCES® RECEIVES FDA PMA SUPPLEMENT APPROVAL
FOR
ITS NEXT-GENERATION LAP-BAND® 2.0 FLEX
* RESHAPE LIFESCIENCES INC - INITIATING U.S. PRODUCT LAUNCH
* RESHAPE LIFESCIENCES INC - PREPARING FOR OUR U.S. PRODUCT
LAUNCH
OF LAP-BAND 2.0 FLEX
Source text for Eikon: ID:nGNX5tlxwz
Further company coverage: RSLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity